Current and Emerging Therapies in Pancreatic Cancer (Record no. 8891)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 04705nam a22004817a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240305192558.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 220824b |||||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 3319582569 |
| International Standard Book Number | 9783319582566 |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | DLC |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.33 SAA |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Tanios Bekaii-Saab |
| 9 (RLIN) | 43056 |
| 222 ## - KEY TITLE | |
| Key title | adenocarcinoma advanced pancreatic cancer Ann Surg associated atic cancer bevacizumab bile duct biliary borderline resectable BRCA1 BRCA2 BRPC capecitabine carcinoma celiac chemoradiation chemotherapy Clin Oncol clinical trials combination compared cyst cystic diagnosis dose endoscopic endoscopic ultrasound erlotinib EUS-guided evaluation fluorouracil FOLFIRINOX Gastroenterol Gastrointest Endosc gemcitabine gene genetic germline GVAX imaging inhibition inhibitor invasive IPMN irinotecan KRAS LAPC lesions liver locally advanced pancreatic malignant median meta-analysis metastatic metastatic pancreatic cancer months mucinous multicenter mutations nab-paclitaxel neoadjuvant neuroendocrine tumors Oncology overall survival oxaliplatin pancre pancreatic adenocarcinoma pancreatic cancer pancreatic ductal pancreatic ductal adenocarcinoma pancreatic tumors pancreaticoduodenectomy pathway patients with advanced patients with metastatic patients with pancreatic PDAC phase II study portal preoperative prognostic protein radiation therapy randomized regimen resectable pancreatic cancer resection risk of PC SBRT screening stent stromal superior mesenteric surgery surgical resection syndrome target tion tissue TNFerade toxicity treatment unresectable vaccine vascular vein |
| 245 ## - TITLE STATEMENT | |
| Title | Current and Emerging Therapies in Pancreatic Cancer |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Mayo Clinic Cancer Center Scottsdale, AZ USA: |
| Name of publisher, distributor, etc. | Springer, |
| Date of publication, distribution, etc. | c2017 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 379 pages |
| 505 ## - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Contents: Pancreatic Cancer Epidemiology and Environmental Risk Factors -- Anatomy of the Pancreas and Biliary Tree -- Pathology: Preneoplastic and Neoplastic Disease and Molecular Genetics -- Screening for Pancreatic Cancer: Who to Screen and How to Follow-up? -- Staging and Prognostic Implications -- Current and Emerging Therapies in Pancreatic Cancer -- Imaging of Pancreatic Malignancies -- Advanced Endoscopic Procedures -- How to Treat Resectable Disease -- The Management of Locally Advanced Non-Metastatic Pancreas Cancer -- Cytotoxic Therapy in Advanced Pancreatic Cancer: Where We Are and Where We Are Headed -- Molecularly Targeted Therapies in Pancreatic Cancer -- Targeting the Tumor Microenvironment -- Synthetic Lethality: Achilles Heel in Select Patient Subpopulations -- Immune Therapies in Pancreatic Cancer -- Vaccine Therapy in Pancreatic Cancer -- Virotherapies in Pancreatic Cancer -- Novel Radiotherapy Modalities -- The Role for Palliative Surgical Interventions in Pancreatic Cancer -- Current and Emerging Therapies in Pancreatic Cancer: Do They Provide Value?. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | This book provides a comprehensive, state-of-the art review of current and new therapies in treating pancreatic cancer. In addition to discussing the current landscape for treating various stages of pancreatic cancer, the text highlights several standard and emerging approaches, with a particular emphasis on novel endoscopic, surgical, chemotherapeutic, radiotherapeutic, targeted, and immunotherapeutic strategies. The volume also features concepts on the potential economic effects associated with the development and implementation of new treatments in pancreatic cancer. Written by experts from a variety of integrative disciplines, Current and Emerging Therapies in Pancreatic Cancer is a valuable resource for oncologists, gastroenterologists, surgeons, and other professionals who treat and manage patients with pancreatic cancer. |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
| General subdivision | Medicine |
| 9 (RLIN) | 31465 |
| General subdivision | Pancreas -- Cancer -- Treatment |
| 9 (RLIN) | 43057 |
| General subdivision | Gastroenterology |
| 9 (RLIN) | 31323 |
| General subdivision | Hepatology |
| 9 (RLIN) | 43058 |
| General subdivision | Medicine |
| 9 (RLIN) | 31465 |
| General subdivision | Oncology |
| 9 (RLIN) | 29434 |
| General subdivision | MEDICAL / Oncology |
| 9 (RLIN) | 29196 |
| General subdivision | Pancreatic Neoplasms -- therapy |
| 9 (RLIN) | 43059 |
| General subdivision | Medical -- Gastroenterology |
| 9 (RLIN) | 27025 |
| General subdivision | Medical -- Oncology |
| 9 (RLIN) | 29196 |
| General subdivision | Hepatology |
| 9 (RLIN) | 43060 |
| General subdivision | Oncology |
| 9 (RLIN) | 29434 |
| General subdivision | Gastroenterology |
| 9 (RLIN) | 31323 |
| General subdivision | Clinical medicine |
| 9 (RLIN) | 27812 |
| General subdivision | Oncology |
| 9 (RLIN) | 29434 |
| General subdivision | Gastroenterology |
| 9 (RLIN) | 31323 |
| General subdivision | Medical / Oncology / General |
| 9 (RLIN) | 26891 |
| General subdivision | Medical / Hepatology |
| 9 (RLIN) | 27670 |
| General subdivision | Medical / Gastroenterology |
| 9 (RLIN) | 27025 |
| General subdivision | Medical / Clinical Medicine |
| 9 (RLIN) | 26816 |
| General subdivision | Medical › Oncology › General |
| 9 (RLIN) | 26780 |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| 9 (RLIN) | 43061 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | ddc |
| Koha item type | E-BOOKS |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Collection | Home library | Current library | Shelving location | Date acquired | Total checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | 08/24/2022 | 616.33 SAA | EBS12891 | 08/24/2022 | 08/24/2022 | E-BOOKS |